Cilansetron
Alternative Names: KC 9946Latest Information Update: 03 Mar 2010
Price :
$50 *
At a glance
- Originator Solvay Pharmaceuticals
- Class Irritable bowel syndrome therapies
- Mechanism of Action Serotonin 3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Irritable bowel syndrome
Most Recent Events
- 11 Jul 2007 No development reported - Phase-III for Irritable bowel syndrome in Europe (PO)
- 11 Jul 2007 No development reported - Phase-III for Irritable bowel syndrome in United Kingdom (PO)
- 29 Nov 2005 Suspended - Preregistration for Irritable bowel syndrome in USA (PO)